cailynn created a new blog entry
2 days, 3 hours ago public
Next-Gen Checkpoint Therapy: Shifting to Fragments and Bispecifics
As immunotherapy moves beyond traditional PD-1/PD-L1 monotherapy, drug discovery faces new technical bottlenecks. Creative Biolabs addresses these shifts with custom antibody fragment...